trending Market Intelligence /marketintelligence/en/news-insights/trending/mhfuluwvxk4yszaj00v8pa2 content esgSubNav
In This List

Biocept appoints chief commercial officer

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection

Video

S&P Capital IQ Pro | Powered by Advanced Visualization

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge


Biocept appoints chief commercial officer

San Diego molecular diagnostic company Biocept Inc. appointed Edwin Hendrick as its senior vice president and chief commercial officer.

Hendrick has specialized in the diagnostics space, most recently at GenomeDx Biosciences Inc. and previously as executive vice president of sales and marketing at PLUS Diagnostics Inc., which was purchased by Labcorp of America in 2005. He has also served at Ventana Medical Systems SA and Abbott Laboratories.

Biocept has liquid biopsy assays for many types of cancer that analyze tumor-associated biomarkers in patients. The tests identify cancer mutations, providing insight into possible treatments.